Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice

PPT1 and PPT2 encode two lysosomal thioesterases that catalyze the hydrolysis of long chain fatty acyl CoAs. In addition to this function, PPT1 (palmitoyl-protein thioesterase 1) hydrolyzes fatty acids from modified cysteine residues in proteins that are undergoing degradation in the lysosome. PPT1 deficiency in humans causes a neurodegenerative disorder, infantile neuronal ceroid lipofuscinosis (also known as infantile Batten disease). In the current work, we engineered disruptions in the PPT1 and PPT2 genes to create “knockout” mice that were deficient in either enzyme. Both lines of mice were viable and fertile. However, both lines developed spasticity (a “clasping” phenotype) at a median age of 21 wk and 29 wk, respectively. Motor abnormalities progressed in the PPT1 knockout mice, leading to death by 10 mo of age. In contrast, the majority of PPT2 mice were alive at 12 mo. Myoclonic jerking and seizures were prominent in the PPT1 mice. Autofluorescent storage material was striking throughout the brains of both strains of mice. Neuronal loss and apoptosis were particularly prominent in PPT1-deficient brains. These studies provide a mouse model for infantile neuronal ceroid lipofuscinosis and further suggest that PPT2 serves a role in the brain that is not carried out by PPT1.

[1]  M. Haltia The Neuronal Ceroid–Lipofuscinoses , 2003, Journal of neuropathology and experimental neurology.

[2]  C. Tilikete,et al.  Adult neuronal ceroid lipofuscinosis with palmitoyl‐protein thioesterase deficiency: First adult‐onset patients of a childhood disease , 2001, Annals of neurology.

[3]  S. Hofmann,et al.  Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. , 2001, Human molecular genetics.

[4]  J. Richardson,et al.  Microsomal triglyceride transfer protein expression during mouse development. , 2000, Journal of lipid research.

[5]  Jonathan D. Cooper,et al.  Targeted Disruption of the Cln3 Gene Provides a Mouse Model for Batten Disease , 1999, Neurobiology of Disease.

[6]  A. Chapelle,et al.  The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8 , 1999, Nature Genetics.

[7]  G. Johnson,et al.  A mouse gene knockout model for juvenile ceroid‐lipofuscinosis (batten disease) , 1999, Journal of neuroscience research.

[8]  S. Mole Batten's disease: eight genes and still counting? , 1999, The Lancet.

[9]  R. Campbell,et al.  Characterization of a human MHC class III region gene product with S-thioesterase activity. , 1999, The Biochemical journal.

[10]  J. McNamara,et al.  Seizure disorders in mutant mice: Relevance to human epilepsies , 1999, Current Opinion in Neurobiology.

[11]  C. Catsman-Berrevoets,et al.  A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants , 1999, Journal of medical genetics.

[12]  A. Messer,et al.  An early-onset congenic strain of the motor neuron degeneration (mnd) mouse. , 1999, Molecular genetics and metabolism.

[13]  S. Hofmann,et al.  Structure of the human palmitoyl-protein thioesterase-2 gene (PPT2) in the major histocompatibility complex on chromosome 6p21.3. , 1999, Genomics.

[14]  P. Meikle,et al.  Prevalence of lysosomal storage disorders. , 1999, JAMA.

[15]  Len A. Pennacchio,et al.  Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice , 1998, Nature Genetics.

[16]  K. Wisniewski,et al.  Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. , 1998, The Journal of clinical investigation.

[17]  L. Peltonen,et al.  Mouse palmitoyl protein thioesterase: gene structure and expression of cDNA. , 1998, Genome research.

[18]  L. Donahue,et al.  Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9. , 1998, American journal of medical genetics.

[19]  J. Martin,et al.  Phenotype analysis in neurological models of human disease. , 1998, Neuropathology and applied neurobiology.

[20]  E. Brambilla,et al.  TUNEL Apoptotic Cell Detection in Tissue Sections: Critical Evaluation and Improvement , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  S. Hofmann,et al.  Molecular Cloning and Expression of Palmitoyl-protein Thioesterase 2 (PPT2), a Homolog of Lysosomal Palmitoyl-protein Thioesterase with a Distinct Substrate Specificity* , 1997, The Journal of Biological Chemistry.

[22]  R. Hammer,et al.  Sustained somatic gene inactivation by viral transfer of Cre recombinase , 1996, Nature Biotechnology.

[23]  S. Hofmann,et al.  Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Len A. Pennacchio,et al.  Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1) , 1996, Science.

[25]  C. Slaughter,et al.  Molecular cloning and expression of palmitoyl-protein thioesterase. , 1994, The Journal of biological chemistry.

[26]  R. Bronson,et al.  Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease) , 1993, Annals of neurology.

[27]  R. Hammer,et al.  LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation , 1992, Cell.

[28]  W. Bode,et al.  cystatins: protein inhibitors of cysteine proteinases , 2001 .

[29]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[30]  S. Hofmann,et al.  3 Positional candidate gene cloning of CLN1 , 2001 .

[31]  T. Willnow,et al.  Homologous recombination for gene replacement in mouse cell lines. , 1994, Methods in cell biology.